Dai Han Pharmaceutical Co (XKRX:023910) EPS (Basic) : ₩5,108.00 (TTM As of Jun. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co EPS (Basic)?

Dai Han Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Jun. 2024 was ₩1,364.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩5,108.00.

Dai Han Pharmaceutical Co's EPS (Diluted) for the three months ended in Jun. 2024 was ₩1,364.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩5,108.00.

Dai Han Pharmaceutical Co's EPS without NRI for the three months ended in Jun. 2024 was ₩1,356.86. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 5,062.30.

During the past 12 months, Dai Han Pharmaceutical Co's average EPS without NRIGrowth Rate was 13.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 7.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Dai Han Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 88.70% per year. The lowest was -7.30% per year. And the median was 25.50% per year.

Dai Han Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Dai Han Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co EPS (Basic) Chart

Dai Han Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

4,694.00

2,897.00

3,778.00

4,171.00

4,834.00

Dai Han Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EPS (Basic)	Get a 7-Day Free Trial															1,253.00	1,336.00	1,002.00	1,406.00	1,364.00

Dai Han Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Dai Han Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(28426.315	-	0)	/	5.880
	=	4,834.41

Dai Han Pharmaceutical Co's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(8018.225	-	0)	/	5.878
	=	1,364.11

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,108.00

Dai Han Pharmaceutical Co (XKRX:023910) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Dai Han Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dai Han Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR

Website

http://www.daihan.com

Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co Headlines

No Headlines